I will chirp in here for this one. I feel a Sepsis drug will be at least a $5 Billion a year drug. If we do a deal early, like after phase 2 & perfect results in humans, we will be able to strike a deal for 10% gross & a big chunk down ($1.2-$1.6 Billion). I'm guestimating on Imclone #'s & taking into account they went through phase 3. They got $1.9 Billion down & 37% of the US market. If the big pharmaceutical co. has to pay for Phase 3, we would have to give up some piece of that pie. Since we are small, BIG $ down would be more vital now. We have 3 or more things now we could then finance & take through Phase 3 ourselves. Those 3 or so drugs will generate many more Billions of income on a yearly basis.
The $1,000 a share figure will come faster than you think. When we get our Sepsis treatment in humans & it works, life as we know it will have changed. If you think about it, it already kinda has.
P.S. I would safely say that those other 3 will generate alot of speculation & a very big buzz. They value a company on it's pipelines & safe to say we would be at some very big times future earnings. Maybe even Microsoft big, the funny part is at that point we are just getting started, Lol. I'm in.
News 
Market Data 
Discover 
